Evotec SE (EVO) - Long-Term Debt to Capital

Corporate emblem and logo of evotec.com (EVO)

Evotec SE (EVO) generates revenue by conducting preclinical tests and laboratory searches for new formulas for pharmaceutical giants, while growth is driven by Just-Evotec Biologics AI factories and contracts with Sandoz and Bristol Myers. This price chart, which clearly demonstrates the changes, shows that the indicator is 0.58. The business strategy relies on deep R&D symbiosis with large corporations and occasional acquisitions of niche AI services.

Evotec Corp (EVO) - Long-Term Debt to Equity from 07/04/2022 to 10/30/2026

Analytical breakdowns for Evotec SE (EVO)

- share price and expert price forecast:
Price Performance Chart Evotec AG|EVO - Analyst Consensus Forecast
- market capitalization indicators:
Market Capitalization Evotec SE|EVO - Total Company Value
- company book value details:
Accounting Value of a Share Evotec|EVO - Company Book Value|Market Cap to Net Assets Ratio evotec.com|EVO - Company Total Assets
- company liabilities and liquidity data:
Total Debt to Capital Evotec SE|EVO - Long-Term Debt to Equity Ratio|Ratio of Short-Term Indebtedness to Capital evotec.com|EVO - Company Total Debt|Debt to Book Capital Evotec SE|EVO - Company Long-Term Debts|Short-Term Debt Evotec|Interim Coverage Ratio evotec.com
- earnings and valuation multiples indicators:
EVO - Net Income
General company analysis:Evotec AG, EVO
Core merchandise of evotec.com

Long-term financing is critical for the scalable platform model of Evotec SE (EVO) when expanding its technological database and accelerating pharmaceutical projects. By analyzing the change in long-term debt-to-equity on GURU.Markets, an investor assesses the share of liabilities with a maturity of over one year within the capital structure, which allows for the determination of the business's financial stability and the extent to which its development depends on borrowed funds.

Key competitors

IQV: Long-Term Debt to Capital Coefficient|Long-Term Debt to Capital LH|Long-Term Debt to Capital Medpace Corp (MEDP)|Long-Term Debt to Equity ICON Plc ICLR|Long-Term Debt to Capital Coefficient CRL|FTRE - Long-Term Debt to Equity|Lifecore Biomedical (LFCR) - Long-Term Debt to Equity Ratio|OABI: Long-Term Debt to Capital|Inotiv Corporation (NOTV) - Long-Term Debt to Capital|Long-Term Debt to Equity Ratio CDMO|CTLT: Long-Term Debt to Capital Coefficient|Long-Term Debt to Equity Ratio SCPX (Scorpius Holdings)